Table 3 Length of hospital stay, percent creatinine rise, modified Rankin score at discharge and blood product utilization between the study groups
Non-HES group (n=72) | HES group (n=57) | *p value | |
|---|---|---|---|
Length of ICU stay† | 10 (8–13) | 14 (11–19.5) | 0.001 |
Length of hospital stay† | 14 (12–17) | 19 (14–26) | 0.001 |
30 day mortality | 11 (15.3%) | 7 (12.2%) | 0.79 |
Percentage ∆Cr in patients with primary outcome† | 7.1 (0–27) | 12.5 (0–37.5) | 0.74 |
Modified Rankin score (discharge) | |||
0 | 8 (11.1%) | 2 (3.5%) | 0.38 |
1 | 26 (36.1%) | 30 (52.6%) | |
2 | 14 (19.4%) | 7 (12.3%) | |
3 | 7 (9.7%) | 4 (7%) | |
4 | 5 (6.9%) | 6 (10.5%) | |
5 | 1 (1.4%) | 1 (1.7%) | |
death | 11 (15.3%) | 7 (12.3%) | |
Blood product usage‡ | |||
5% PPF | 24.31 (119.85) | 26.32 (102.25) | 0.51 |
PRBC | 184.65 (428.64) | 388.12 (610.98) | 0.006 |
FFP | 30.67 (131.42) | 82.84 (299.60) | 0.43 |
Platelet | 34.04 (105.06) | 109.30 (445.32) | 0.57 |